![]() | |||||||
lose weight | |||||||
NEWS | |||||||
Steve lost 40.5kg (6st 5lb) in 6 months - The Fast 800 When research scientist Steve, 55, started his weight loss journey, he was feeling unhappy and uncomfortable in his body.
| |||||||
Woman Who Lost More Than 27 Kg Shares 3 Lifestyle Habits That Helped Her Shed Extra Kilos Losing weight is never an easy task. While discipline and ... While these weight loss ways can help you lose weight, it is always a ...
| |||||||
Diet that makes middle-age French women's figures the envy of the world. It sheds a stone in ... The Régime isn't just about losing weight. It's also about a mental ... If you have more than 20 kilos to lose, you could drop as much as a stone in a ...
| |||||||
Balance your blood sugars and lose weight with a low-carb food plan - OurAuckland Join Sheryl Takayama, local nutritionist and weight-loss coach, for this free talk at Orewa Library. Sheryl has personally maintained a 30kg weight ...
| |||||||
Pfizer expands obesity drug pipeline with $7.3 billion deal to buy Metsera - CNBC Pfizer said on Monday it would acquire weight-loss drug developer Metsera in a deal valued up to $7.3 billion.
| |||||||
Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion - Yahoo Finance (Reuters) -Pfizer (PFE) said on Monday it would acquire weight-loss drug developer Metsera (MTSR) for up to $4.9 billion to secure its position in ...
| |||||||
The evolution of the obesity drug market - Nature Initially developed as type 2 diabetes drugs, the emergence of GLP-1 receptor agonists (GLP-1 RAs) as effective weight loss agents has transformed the ...
| |||||||
Pfizer to buy weight-loss drug developer Metsera in $7.3 billion deal | Reuters Pfizer said on Monday it would acquire weight-loss drug developer Metsera in a deal valued up to $7.3 billion, which includes future payments, ...
| |||||||
Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion - WSJ Pfizer on Monday said it would pay an initial $47.50 a share in cash for Metsera, a nearly 43% premium to Friday's closing price of $33.32 for the ...
| |||||||
Novel Quintuple Agonist for Weight Loss, Glucose Control? - Medscape A compound comprising five agonists that together tackle weight loss, glucose reduction, insulin sensitization, and blood fat normalization shows ...
| |||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
![]() |
Send Feedback |